Avsar YK, Karagul-Yuceer Y, Drake MA, Singh TK, Yoon Y, Cadwallader KR
Given their dual benefits in obesity and inflammation regulation, GLP-1RAs medications hold potential as disease-modifying therapies for OA
32 GST in regulation of MAPK pathway Besides metabolite detoxification, GST also exhibits ligand-binding properties that allow the enzyme to interact covalently and noncovalently with compounds, resulting in inhibition of conjugation activity
If so, this guide has researchers covered
Furthermore, specific alterations in microRNA (miRNA) expression profiles (e.g., miR-146a, miR-27b-3p) have been identified as sensitive indicators of epigenetic disruption, modulating downstream pathways involved in cell cycle control, metabolism, and stress responses [165,166,167]
see our previous GPnotebook Shortcut on diagnosis)